arrow_back Back Filing freshness 20-F Q4 FY2025 SEC EDGAR

HUTCHMED (China) Ltd

HCM
$11.82 ▲ +0.28 (+2.43%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
13 Visible periods
5 Metrics
Peer-ranked Benchmarks
Price Chart
59
Health
Fair
Bullish
auto_awesome

Analytical Summary

HUTCHMED (China) Ltd shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap
Dividend Yield
Revenue Growth
Op. Margin
ROIC
FCF / Share
Trailing P/E
Price / Book
FCF Yield
Debt / Equity 0.10
info Valuation on last close. End-of-day price, Aug 6, 2026.

13-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Long-Term Debt Long-term obligations
$93.16M
↑ +12.5%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability
42
Returns
95
Financial Health
54
Cash Quality
17

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 13 quarters